Exercise as a Mean to Control Low‐Grade Systemic Inflammation
Open accessAbstract
Chronic noncommunicable diseases (CNCDs), which include cardiovascular disease, some cancers, for example, colon cancer, breast cancer, and type 2 diabetes, are reaching epidemic proportions worldwide. It has now become clear that low‐grade chronic inflammation is a key player in the pathogenesis of most CNCDs. Given that regular exercise offers protection against all causes of mortality, primarily by protection against atherosclerosis and insulin resistance, we suggest that exercise may exert some of its beneficial health effects by inducing anti‐inflammatory actions. Recently, IL‐6 was introduced as the first myokine, defined as a cytokine, which is produced and released by contracting skeletal muscle fibres, exerting its effects in other organs of the body. We suggest that skeletal muscle is an endocrine organ and that myokines may be involved in mediating the beneficial effects against CNCDs associated with low‐grade inflammation.
AI snapshot
Written from the paper’s full text.
TL;DR
This narrative review argues that regular exercise protects against chronic noncommunicable diseases (CNCDs) partly through anti-inflammatory actions, with contracting skeletal muscle acting as an endocrine organ that releases myokines—chiefly IL-6. It proposes that the acute IL-6 response to exercise suppresses TNF-α and may thereby counter the low-grade systemic inflammation underlying atherosclerosis and insulin resistance.
Key findings
- Low-grade chronic inflammation is characterized by a 2- to 3-fold elevation in systemic concentrations of pro- and anti-inflammatory cytokines, cytokine antagonists, and C-reactive protein (CRP); CRP is described as a stronger independent risk factor for cardiovascular disease than LDL cholesterol.
- Exercise provokes a cytokine response distinct from sepsis: the classical proinflammatory cytokines TNF-α and IL-1β generally do not increase, whereas circulating IL-6 rises exponentially (up to 100-fold) and declines postexercise; the magnitude depends on exercise duration, intensity, and muscle mass involved.
- In an experimental human endotoxin model, resting subjects showed a 2- to 3-fold increase in circulating TNF-α, whereas 3 hours of ergometer cycling (endotoxin given at 2.5 hours) "totally blunted" the TNF-α response; the effect could be mimicked by IL-6 infusion.
- TNF-α is presented as a direct pathogenic player in insulin resistance: infusion into healthy humans impaired skeletal muscle glucose uptake via altered insulin signalling (increased p70 S6 kinase, ERK-1/2, JNK; increased serine and reduced tyrosine phosphorylation of IRS-1; impaired Akt substrate 160 phosphorylation), and increased whole-body lipolysis by 40%. In contrast, in vivo human studies provide "little or no evidence" that IL-6 is a direct player in the metabolic syndrome; IL-6 is instead identified as a novel lipolytic factor.
Methods
- Narrative review; no primary data collection or systematic search strategy is described.
- Synthesizes cross-sectional studies (physical inactivity associated with low-grade systemic inflammation in healthy subjects, elderly people, and patients with intermittent claudication), longitudinal training studies (reductions in CRP), and mechanistic human infusion/cell-culture studies.
- Describes one experimental human model in detail: healthy volunteers randomized to rest or exercise prior to a low-dose *E. coli* endotoxin injection, with TNF-α response as the outcome.
Limitations
- Stated by the paper: the link between the acute anti-inflammatory effects of exercise and its long-term benefits "has not yet been proven"; an alternative explanation offered is that exercise protects against atherosclerosis and only indirectly against vascular and systemic inflammation.
- Stated by the paper: the role of IL-6 in insulin resistance is "highly controversial," with human circulating IL-6 levels shown to be associated or not associated with insulin resistance across studies.
- Evident from the text: as a narrative review it relies on cited literature rather than a systematic, reproducible search, and several key mechanistic claims rest on animal or cell-culture work (e.g., IL-6 knockout mice, 3T3-L1 adipocytes) whose supraphysiological doses the authors themselves note are "probably not relevant to human physiology."
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 105 cited sources checked · 0 supported · 0 flagged
- Findingcitation
TNF-α directly impairs glucose uptake and metabolism by altering insulin signal transduction.
“TNF-α directly impaired glucose uptake and metabolism by altering insulin signal transduction.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [44] Plomgaard P Bouzakri K Krogh-Madsen R Mittendorfer B Zierath JR Pedersen BK Tumor necrosis factor-α induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation Diabetes 2005 54 10 2939 2945 16186396 source
Not checked in the free run.
- Findingcitation
These signalling effects are associated with impaired phosphorylation of Akt substrate 160, the most proximal step in the canonical insulin signalling cascade regulating GLUT4 translocation and glucose uptake.
“These signalling effects were associated with impaired phosphorylation of Akt substrate 160, the most proximal step identified in the canonical insulin signalling cascade regulating GLUT4 translocation and glucose uptake.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [44] Plomgaard P Bouzakri K Krogh-Madsen R Mittendorfer B Zierath JR Pedersen BK Tumor necrosis factor-α induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation Diabetes 2005 54 10 2939 2945 16186396 source
Not checked in the free run.
- Findingown data
In resting subjects, endotoxin induced a 2- to 3-fold increase in circulating levels of TNF-α.
“In resting subjects, endotoxin induced a 2- to 3-fold increase in circulating levels of TNF-α.”
Quote in the paperSubstantial claim - Findingown data
When subjects performed 3 hours of ergometer cycling and received the endotoxin bolus at 2.5 hours, the TNF-α response was totally blunted.
“In contrast, when the subjects performed 3 hours of ergometer cycling and received the endotoxin bolus at 2.5 hours, the TNF-α response was totally blunted.”
Quote in the paperSubstantial claim - Premisecitation
Low-grade chronic inflammation is a key player in the pathogenesis of most chronic noncommunicable diseases.
“It has now become clear that low-grade chronic inflammation is a key player in the pathogenesis of most CNCDs.”
- Also stated in: § 1. INTRODUCTION · boosted
“It has now become clear that low-grade chronic inflammation is a key player in the pathogenesis of most NCDCs.”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [5] Libby P Inflammation in atherosclerosis Nature 2002 420 6917 868 874 12490960 source
Not checked in the free run.
- cites [6] Packard RRS Libby P Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction Clinical Chemistry 2008 54 1 24 38 18160725 source
Not checked in the free run.
- cites [7] Dandona P Aljada A Bandyopadhyay A Inflammation: the link between insulin resistance, obesity and diabetes Trends in Immunology 2004 25 1 4 7 14698276 source
Not checked in the free run.
- cites [8] Petersen AMW Pedersen BK The anti-inflammatory effect of exercise Journal of Applied Physiology 2005 98 4 1154 1162 15772055 source
Not checked in the free run.
- Also stated in: § 1. INTRODUCTION · boosted
- Premisecitation
Physical activity induces an increase in systemic levels of cytokines with anti-inflammatory properties.
“Recent findings demonstrate that physical activity induces an increase in the systemic levels of a number of cytokines with anti-inflammatory properties [8, 17]”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [8] Petersen AMW Pedersen BK The anti-inflammatory effect of exercise Journal of Applied Physiology 2005 98 4 1154 1162 15772055 source
Not checked in the free run.
- cites [17] Pedersen BK State of the art reviews: health benefits related to exercise in patients with chronic low-grade systemic inflammation American Journal of Lifestyle Medicine 2007 1 4 289 298
Not checked in the free run.
- Premisecitation
Low-grade systemic inflammation is associated with atherosclerosis and type 2 diabetes.
“a number of studies have confirmed an association between low-grade systemic inflammation on one hand and atherosclerosis and type 2 diabetes on the other [8].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [8] Petersen AMW Pedersen BK The anti-inflammatory effect of exercise Journal of Applied Physiology 2005 98 4 1154 1162 15772055 source
Not checked in the free run.
- Premisecitation
Skeletal muscle is an endocrine organ.
“We suggest that skeletal muscle is an endocrine organ and that myokines may be involved in mediating the beneficial effects against CNCDs associated with low-grade inflammation.”
- Also stated in: § 1. INTRODUCTION · plain
“skeletal muscle has recently been identified as an endocrine organ, which produces and releases cytokines (also called myokines) [18, 19].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [18] Pedersen BK Steensberg A Fischer C Searching for the exercise factor: is IL-6 a candidate? Journal of Muscle Research and Cell Motility 2003 24 2-3 113 119 14609022 source
Not checked in the free run.
- cites [19] Febbraio MA Pedersen BK Contraction-induced myokine production and release: is skeletal muscle an endocrine organ? Exercise and Sport Sciences Reviews 2005 33 3 114 119 16006818 source
Not checked in the free run.
- Also stated in: § 1. INTRODUCTION · plain
- Premisecitation
Regular physical activity protects against premature death independent of obesity.
“Moreover, regular physical activity appears to protect against premature death independent of obesity [10, 11].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [10] Khaw KT Wareham N Bingham S Welch A Luben R Day N Combined impact of health behaviours and mortality in men and women: the EPIC-Norfolk prospective population study PLoS Medicine 2008 5 1 p. e12 18184033 PMC2174962 source
Not checked in the free run.
- cites [11] Sui X LaMonte MJ Laditka JN Cardiorespiratory fitness and adiposity as mortality predictors in older adults Journal of the American Medical Association 2007 298 21 2507 2516 18056904 PMC2692959 source
Not checked in the free run.
- Interpretationreasoning
Myokines may be involved in mediating the beneficial effects against chronic noncommunicable diseases associated with low-grade inflammation.
“myokines may be involved in mediating the beneficial effects against CNCDs associated with low-grade inflammation”
Quote in the paperSubstantial claim - Premisecitation
Plasma concentrations of IL-6 and TNF-α predict the risk of myocardial infarction.
“Plasma concentrations of IL-6 [31] and TNF-α have been shown to predict the risk of myocardial infarction in several studies [32]”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [31] Bennet AM Prince JA Fei G-Z Interleukin-6 serum levels and genotypes influence the risk for myocardial infarction Atherosclerosis 2003 171 2 359 367 14644408 source
Not checked in the free run.
- cites [32] Reilly MP Rohatgi A McMahon K Plasma cytokines, metabolic syndrome, and atherosclerosis in humans Journal of Investigative Medicine 2007 55 1 26 35 17441409 source
Not checked in the free run.
- Premisecitation
Skeletal muscle produces and releases cytokines, also called myokines.
“skeletal muscle has recently been identified as an endocrine organ, which produces and releases cytokines (also called myokines) [18, 19].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [18] Pedersen BK Steensberg A Fischer C Searching for the exercise factor: is IL-6 a candidate? Journal of Muscle Research and Cell Motility 2003 24 2-3 113 119 14609022 source
Not checked in the free run.
- cites [19] Febbraio MA Pedersen BK Contraction-induced myokine production and release: is skeletal muscle an endocrine organ? Exercise and Sport Sciences Reviews 2005 33 3 114 119 16006818 source
Not checked in the free run.
- Premisecitation
Chronic low-grade systemic inflammation is characterized by a 2- to 3-fold elevation in systemic concentrations of proinflammatory and anti-inflammatory cytokines, natural occurring cytokine antagonists, and C-reactive protein.
“Chronic low-grade systemic inflammation has been characterized by a 2- to 3-fold elevation in the systemic concentrations of proinflammatory and anti-inflammatory cytokines, natural occurring cytokine antagonists, and the acute phase reactant C-reactive protein (CRP) [13, 22].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [13] Wilund KR Is the anti-inflammatory effect of regular exercise responsible for reduced cardiovascular disease? Clinical Science 2007 112 11-12 543 555 17459004 source
Not checked in the free run.
- cites [22] Bruunsgaard H Physical activity and modulation of systemic low-level inflammation Journal of Leukocyte Biology 2005 78 4 819 835 16033812 source
Not checked in the free run.
- Premisecitation
Physical inactivity is a stronger predictor of chronic diseases than hypertension, hyperlipidemia, diabetes, and obesity for all-cause mortality.
“Physical inactivity has been identified as a stronger predictor of these chronic diseases than risk factors such as hypertension, hyperlipidemia, diabetes, and obesity for all-cause mortality [9].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [9] Myers J Kaykha A George S Fitness versus physical activity patterns in predicting mortality in men American Journal of Medicine 2004 117 12 912 918 15629729 source
Not checked in the free run.
- Premisecitation
C-reactive protein is a stronger independent risk factor for cardiovascular disease than the low-density lipoprotein cholesterol level.
“CRP has emerged as a particularly stronger independent risk factor for cardiovascular disease than the low-density lipoprotein cholesterol level [13, 33, 34].”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [13] Wilund KR Is the anti-inflammatory effect of regular exercise responsible for reduced cardiovascular disease? Clinical Science 2007 112 11-12 543 555 17459004 source
Not checked in the free run.
- cites [33] Cook NR Buring JE Ridker PM The effect of including C-reactive protein in cardiovascular risk prediction models for women Annals of Internal Medicine 2006 145 1 21 29 16818925 source
Not checked in the free run.
- cites [34] Ridker PM Rifai N Rose L Buring JE Cook NR Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events The New England Journal of Medicine 2002 347 20 1557 1565 12432042 source
Not checked in the free run.
- Interpretationreasoning
Exercise may exert some of its beneficial health effects by inducing anti-inflammatory actions.
“we suggest that exercise may exert some of its beneficial health effects by inducing anti-inflammatory actions.”
Quote in the paperSubstantial claim - Premisecitation
Infusion of recombinant human IL-6 into resting healthy humans does not impair whole body, lower limb, or subcutaneous adipose tissue glucose uptake or endogenous glucose production.
“Infusion of recombinant human (rh) IL-6 into resting healthy humans does not impair whole body, lower limb, or subcutaneous adipose tissue glucose uptake or endogenous glucose production [48, 49].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [48] Steensberg A Fischer CP Sacchetti M Acute interleukin-6 administration does not impair muscle glucose uptake or whole-body glucose disposal in healthy humans The Journal of Physiology 2003 548 2 631 638 12640021 PMC2342867 source
Not checked in the free run.
- cites [49] Lyngsø D Simonsen L Bülow J Interleukin-6 production in human subcutaneous abdominal adipose tissue: the effect of exercise The Journal of Physiology 2002 543 1 373 378 12181307 PMC2290472 source
Not checked in the free run.
- Premisecitation
TNF-α plays a direct role in metabolic syndrome via a direct effect on insulin signaling.
“Growing evidence suggests that TNF-α plays a direct role in metabolic syndrome, via direct effect of TNF-α on insulin signaling [35, 36].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [35] Ruan H Lodish HF Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-α Cytokine and Growth Factor Reviews 2003 14 5 447 455 12948526 source
Not checked in the free run.
- cites [36] Rydén M Arner P Tumour necrosis factor-α in human adipose tissue—from signalling mechanisms to clinical implications Journal of Internal Medicine 2007 262 4 431 438 17875179 source
Not checked in the free run.
- Premisecitation
After adjustment for multiple confounders including IL-6, high plasma TNF concentrations are associated with insulin resistance.
“After adjustment for multiple confounders, including IL-6, high plasma TNF concentrations are associated with insulin resistance [40].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [40] Plomgaard P Nielsen AR Fischer CP Associations between insulin resistance and TNF-α in plasma, skeletal muscle and adipose tissue in humans with and without type 2 diabetes Diabetologia 2007 50 12 2562 2571 17928988 source
Not checked in the free run.
- Interpretationcitation
Findings on TNF effects on both glucose and fat metabolism provide a direct molecular link between low-grade systemic inflammation and the metabolic syndrome.
“The findings with regard to an effect of TNF on both glucose and fat metabolism provide a direct molecular link between low-grade systemic inflammation and the metabolic syndrome [44, 45].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [44] Plomgaard P Bouzakri K Krogh-Madsen R Mittendorfer B Zierath JR Pedersen BK Tumor necrosis factor-α induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation Diabetes 2005 54 10 2939 2945 16186396 source
Not checked in the free run.
- cites [45] Plomgaard P Fischer CP Ibfelt T Pedersen BK van Hall G Tumor necrosis factor-α modulates human in vivo lipolysis The Journal of Clinical Endocrinology & Metabolism 2008 93 2 543 549 18029463 source
Not checked in the free run.
- Premisecitation
TNF-α has a direct insulin-independent effect on S6K and ERK-1/2 in cultured cells.
“TNF-α has been shown to have a direct (insulin-independent) effecton S6K and ERK-1/2 in cultured cells [42, 43].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [42] Glantschnig H Fisher JE Wesolowski G Rodan GA Reszka AA M-CSF, TNFα and RANK ligand promote osteoclast survival by signaling through mTOR/S6 kinase Cell Death and Differentiation 2003 10 10 1165 1177 14502240 source
Not checked in the free run.
- cites [43] Vary TC Deiter G Lang CH Diminished Erk 1/2 and p38 mapk phosphorylation in skeletal muscle during sepsis Shock 2004 22 6 548 554 15545827
Not checked in the free run.
- Interpretationown data
Excessive concentrations of TNF-α negatively regulate insulin signalling and whole-body glucose uptake in humans.
“Thus, excessive concentrations of TNF-alpha negatively regulate insulin signalling and whole-body glucose uptake in humans.”
Quote in the paperSubstantial claim - Premisecitation
When IL-6 deficient mice were treated with IL-6, there was a significant decrease in body fat mass in the IL-6 knockout but not in the wild-type mice.
“In addition, when the mice were treated with IL-6, there was a significant decrease in body fat mass in the IL-6 knockout but not in the wild-type mice.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Wallenius et al. 2002
Not checked in the free run.
- Premisecitation
Accumulating data suggest that IL-6 enhances glucose uptake in myocytes.
“Thus, accumulating data suggest that IL-6 enhances glucose uptake in myocytes [54–57].”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [54] Wallenius V Wallenius K Ahrén B Interleukin-6-deficient mice develop mature-onset obesity Nature Medicine 2002 8 1 75 79 11786910 source
Not checked in the free run.
- cites [55] Glund S Deshmukh A Long YC Interleukin-6 directly increases glucose metabolism in resting human skeletal muscle Diabetes 2007 56 6 1630 1637 17363741 source
Not checked in the free run.
- cites [56] Carey AL Steinberg GR Macaulay SL Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase Diabetes 2006 55 10 2688 2697 17003332 source
Not checked in the free run.
- cites [57] Al-Khalili L Bouzakri K Glund S Lönnqvist F Koistinen HA Krook A Signaling specificity of interleukin-6 action on glucose and lipid metabolism in skeletal muscle Molecular Endocrinology 2006 20 12 3364 3375 16945991 source
Not checked in the free run.
- Premisecitation
In cultured cells, TNF-α induces insulin resistance through increased serine phosphorylation of IRS-1, which converts IRS-1 to an inhibitor of insulin receptor tyrosine kinase activity.
“In cultured cells, TNF-α induces insulin resistance through increased serine phosphorylationof insulin receptor substrate-1 (IRS-1), which subsequently converts IRS-1 to an inhibitor of insulin receptor tyrosinekinase activity [41].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [41] Hotamisligil GS Peraldi P Budavari A Ellis R White MF Spiegelman BM IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α- and obesity-induced insulin resistance Science 1996 271 5249 665 668 8571133 source
Not checked in the free run.
- Premisecitation
Infusion of rhIL-6 into healthy humans to obtain physiological concentrations increased lipolysis in the absence of hypertriacylglyceridemia or changes in catecholamines, glucagon, insulin, or adverse effects in healthy individuals and patients with type 2 diabetes.
“Infusion of rhIL-6 into healthy humans to obtain physiological concentrations of IL-6 increased lipolysis in the absence of hypertriacylglyceridemia or changes in catecholamines, glucagon, insulin, or any adverse effects in healthy individuals as well as patients with type 2 diabetes [49, 50, 58].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [49] Lyngsø D Simonsen L Bülow J Interleukin-6 production in human subcutaneous abdominal adipose tissue: the effect of exercise The Journal of Physiology 2002 543 1 373 378 12181307 PMC2290472 source
Not checked in the free run.
- cites [50] Petersen EW Carey AL Sacchetti M Acute IL-6 treatment increases fatty acid turnover in elderly humans in vivo and in tissue culture in vitro American Journal of Physiology 2005 288 1 E155 E162 15383370 source
Not checked in the free run.
- cites [58] van Hall G Steensberg A Sacchetti M Interleukin-6 stimulates lipolysis and fat oxidation in humans The Journal of Clinical Endocrinology & Metabolism 2003 88 7 3005 3010 12843134 source
Not checked in the free run.
- Premisecitation
Muscle biopsies before and after exercise in humans and rats demonstrate very little IL-6 mRNA in resting muscle, but up to a 100-fold increase in exercising skeletal muscle.
“Thus muscle biopsies obtained before and after exercise in humans and rats demonstrate very little IL-6 mRNA in resting muscle, but up to a 100-fold increase in exercising skeletal muscle [18, 64, 65].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [18] Pedersen BK Steensberg A Fischer C Searching for the exercise factor: is IL-6 a candidate? Journal of Muscle Research and Cell Motility 2003 24 2-3 113 119 14609022 source
Not checked in the free run.
- cites [64] Steensberg A van Hall G Osada T Sacchetti M Saltin B Pedersen BK Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6 The Journal of Physiology 2000 529 1 237 242 11080265 PMC2270169 source
Not checked in the free run.
- cites [65] Ostrowski K Rohde T Asp S Schjerling P Pedersen BK Pro- and anti-inflammatory cytokine balance in strenuous exercise in humans The Journal of Physiology 1999 515 1 287 291 9925898 PMC2269132 source
Not checked in the free run.
- Premisecitation
The magnitude by which plasma IL-6 increases is related to exercise duration, intensity, and muscle mass involved in the mechanical work.
“The magnitude by which plasma IL-6 increases is related to exercise duration, intensity, and muscle mass involved in the mechanical work [13, 18, 60, 62].”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [13] Wilund KR Is the anti-inflammatory effect of regular exercise responsible for reduced cardiovascular disease? Clinical Science 2007 112 11-12 543 555 17459004 source
Not checked in the free run.
- cites [18] Pedersen BK Steensberg A Fischer C Searching for the exercise factor: is IL-6 a candidate? Journal of Muscle Research and Cell Motility 2003 24 2-3 113 119 14609022 source
Not checked in the free run.
- cites [60] Febbraio MA Pedersen BK Muscle-derived interleukin-6: mechanisms for activation and possible biological roles The FASEB Journal 2002 16 11 1335 1347 12205025 source
Not checked in the free run.
- cites [62] Pedersen BK Steensberg A Schjerling P Exercise and interleukin-6 Current Opinion in Hematology 2001 8 3 137 141 11303145 source
Not checked in the free run.
- Premisecitation
IL-6 inhibits lipopolysaccharide-induced TNF-α production in cultured human monocytes and in the human monocytic line U937.
“IL-6 inhibits lipopolysaccharide (LPS)-induced TNF-α production both in cultured human monocytes and in the human monocytic line U937 [66]”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [66] Schindler R Mancilla J Endres S Ghorbani R Clark SC Dinarello CA Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF Blood 1990 75 1 40 47 2294996 source
Not checked in the free run.
- Interpretationreasoning
In vivo studies in humans provide little or no evidence that IL-6 is a direct player in the metabolic syndrome.
“Taken together, it is apparent that in vivo studies in humans provide little or no evidence that IL-6 is a direct player in the metabolic syndrome.”
Quote in the paperSubstantial claim - Interpretationreasoning
IL-6 is a novel lipolytic factor.
“These findings, together with cell culture experiments demonstrating that IL-6 alone markedly increases both lipolysis and fat oxidation, identify IL-6 as a novel lipolytic factor.”
Quote in the paperSubstantial claim - Premisecitation
Working muscle produces IL-6.
“A number of studies have demonstrated that working muscle produces IL-6.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [18] Pedersen BK Steensberg A Fischer C Searching for the exercise factor: is IL-6 a candidate? Journal of Muscle Research and Cell Motility 2003 24 2-3 113 119 14609022 source
Not checked in the free run.
- cites [64] Steensberg A van Hall G Osada T Sacchetti M Saltin B Pedersen BK Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6 The Journal of Physiology 2000 529 1 237 242 11080265 PMC2270169 source
Not checked in the free run.
- cites [65] Ostrowski K Rohde T Asp S Schjerling P Pedersen BK Pro- and anti-inflammatory cytokine balance in strenuous exercise in humans The Journal of Physiology 1999 515 1 287 291 9925898 PMC2269132 source
Not checked in the free run.
- Premisenone given
The classical proinflammatory cytokines TNF-α and IL-1β generally do not increase with exercise.
“The striking difference between exercise and sepsis with regard to cytokine responses is that the classical proinflammatory cytokines, TNF-α and IL-1β, in general do not increase with exercise.”
Quote in the paperSubstantial claim - Premisecitation
rhIL-6 infusion inhibits the endotoxin-induced increase in circulating levels of TNF-α in healthy humans.
“In addition, rhIL-6 infusion inhibits the endotoxin-induced increase in circulating levels of TNF-α in healthy humans [69].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [69] Starkie R Ostrowski SR Jauffred S Febbraio M Pedersen BK Exercise and IL-6 infusion inhibit endotoxin-induced TNF-α production in humans The FASEB Journal 2003 17 8 884 886 12626436 source
Not checked in the free run.
- Premisecitation
The exercise-induced increase in plasma IL-6 levels is followed by increased circulating levels of anti-inflammatory cytokines IL-1ra and IL-10.
“The exercise-induced increase in plasma IL-6 levels is followed by increased circulating levels of well-known anti-inflammatory cytokines such as IL-1ra and IL-10 [28, 48].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [28] Pedersen BK Fischer CP Physiological roles of muscle-derived interleukin-6 in response to exercise Current Opinion in Clinical Nutrition and Metabolic Care 2007 10 3 265 271 17414493 source
Not checked in the free run.
- cites [48] Steensberg A Fischer CP Sacchetti M Acute interleukin-6 administration does not impair muscle glucose uptake or whole-body glucose disposal in healthy humans The Journal of Physiology 2003 548 2 631 638 12640021 PMC2342867 source
Not checked in the free run.
- Premisecitation
Cross-sectional studies demonstrate an association between physical inactivity and low-grade systemic inflammation in healthy subjects, elderly people, and patients with intermittent claudication.
“Cross-sectional studies demonstrate an association between physical inactivity and low-grade systemic inflammation in healthy subjects [71–75], in elderly people [76, 77], and in patients with intermittent claudication [78].”
Quote in the paperSubstantial claim0 of 8 sources checked- cites [71] Fischer CP Berntsen A Perstrup LB Eskildsen P Pedersen BK Plasma levels of interleukin-6 and C-reactive protein are associated with physical inactivity independent of obesity Scandinavian Journal of Medicine & Science in Sports 2006 17 5 580 587 17076827 source
Not checked in the free run.
- cites [72] Halle M Korsten-Reck U Wolfarth B Berg A Low-grade systemic inflammation in overweight children: impact of physical fitness Exercise Immunology Review 2004 10 66 74 15633587
Not checked in the free run.
- cites [73] Geffken DF Cushman M Burke GL Polak JF Sakkinen PA Tracy RP Association between physical activity and markers of inflammation in a healthy elderly population American Journal of Epidemiology 2001 153 3 242 250 11157411 source
Not checked in the free run.
- cites [74] Fallon KE Fallon SK Boston T The acute phase response and exercise: court and field sports British Journal of Sports Medicine 2001 35 3 170 173 11375875 PMC1724337 source
Not checked in the free run.
- cites [75] Mattusch F Dufaux B Heine O Mertens I Rost R Reduction of the plasma concentration of C-reactive protein following nine months of endurance training International Journal of Sports Medicine 2000 21 1 21 24 10683094 source
Not checked in the free run.
- cites [76] Bruunsgaard H Ladelund S Pedersen AN Schroll M Jørgensen T Pedersen BK Predicting death from tumour necrosis factor-alpha and interleukin-6 in 80-year-old people Clinical & Experimental Immunology 2003 132 1 24 31 12653832 PMC1808682 source
Not checked in the free run.
- cites [77] Cesari M Penninx BWJH Pahor M Inflammatory markers and physical performance in older persons: the InCHIANTI study Journals of Gerontology Series A 2004 59 3 242 248 15031308 source
Not checked in the free run.
- cites [78] Tisi PV Hulse M Chulakadabba A Gosling P Shearman CP Exercise training for intermittent claudication: does it adversely affect biochemical markers of the exercise-induced inflammatory response? European Journal of Vascular and Endovascular Surgery 1997 14 5 344 350 9413374 source
Not checked in the free run.
- Interpretationreasoning
Regular exercise protects against diseases associated with chronic low-grade systemic inflammation.
“Regular exercise protects against diseases associated with chronic low-grade systemic inflammation.”
Quote in the paperSubstantial claim - Interpretationcitation
The long-term effect of exercise may to some extent be ascribed to the anti-inflammatory response elicited by an acute bout of exercise, which is partly mediated by muscle-derived IL-6.
“In particular, the long-term effect of exercise may to some extent be ascribed to the anti-inflammatory response elicited by an acute bout of exercise, which is partly mediated by muscle-derived IL-6 [8, 20, 81].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [8] Petersen AMW Pedersen BK The anti-inflammatory effect of exercise Journal of Applied Physiology 2005 98 4 1154 1162 15772055 source
Not checked in the free run.
- cites [20] Pedersen BK The anti-inflammatory effect of exercise: its role in diabetes and cardiovascular disease control Essays in Biochemistry 2006 42 105 117 17144883 source
Not checked in the free run.
- cites [81] Petersen AMW Pedersen BK The role of IL-6 in mediating the anti-inflammatory effects of exercise Journal of Physiology and Pharmacology 2006 57 supplement 10 43 51 17242490
Not checked in the free run.
- May combine two claims. 26
May combine two claims.
FindingcitationTNF-α infusion induces insulin resistance in skeletal muscle of healthy humans without an effect on endogenous glucose production.
“When TNF-α was infused into healthy humans, we found that TNF-α induces insulin resistance in skeletal muscle, without an effect on endogenous glucose production.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [44] Plomgaard P Bouzakri K Krogh-Madsen R Mittendorfer B Zierath JR Pedersen BK Tumor necrosis factor-α induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation Diabetes 2005 54 10 2939 2945 16186396 source
Not checked in the free run.
May combine two claims.
FindingcitationIL-6 increases the glucose infusion rate and glucose oxidation without affecting suppression of endogenous glucose production during a hyperinsulinemic euglycemic clamp in healthy humans.
“Recently, we demonstrated that IL-6 increased the glucose infusion rate [56] and glucose oxidation without affecting the suppression of endogenous glucose production during a hyperinsulinemic euglycemic clamp in healthy humans.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [56] Carey AL Steinberg GR Macaulay SL Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase Diabetes 2006 55 10 2688 2697 17003332 source
Not checked in the free run.
May combine two claims.
FindingcitationTNF-α infusion increases phosphorylation of p70 S6 kinase, ERK-1/2, and JNK, with increased serine and reduced tyrosine phosphorylation of IRS-1.
“TNF-alpha infusion increased phosphorylation of p70 S6 kinase, extracellular signal-regulated kinase-1/2, and c-Jun NH(2)-terminal kinase, concomitant with increased serine and reduced tyrosine phosphorylation of insulin receptor substrate-1.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [44] Plomgaard P Bouzakri K Krogh-Madsen R Mittendorfer B Zierath JR Pedersen BK Tumor necrosis factor-α induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation Diabetes 2005 54 10 2939 2945 16186396 source
Not checked in the free run.
May combine two claims.
PremisecitationIL-6 is produced and released by contracting skeletal muscle fibres and exerts effects in other organs of the body.
“Recently, IL-6 was introduced as the first myokine, defined as a cytokine, which is produced and released by contracting skeletal muscle fibres, exerting its effects in other organs of the body.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [18] Pedersen BK Steensberg A Fischer C Searching for the exercise factor: is IL-6 a candidate? Journal of Muscle Research and Cell Motility 2003 24 2-3 113 119 14609022 source
Not checked in the free run.
- cites [19] Febbraio MA Pedersen BK Contraction-induced myokine production and release: is skeletal muscle an endocrine organ? Exercise and Sport Sciences Reviews 2005 33 3 114 119 16006818 source
Not checked in the free run.
May combine two claims.
PremisecitationRegular exercise offers protection against all causes of mortality, primarily by protection against atherosclerosis and insulin resistance.
“regular exercise offers protection against all causes of mortality, primarily by protection against atherosclerosis and insulin resistance”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [9] Myers J Kaykha A George S Fitness versus physical activity patterns in predicting mortality in men American Journal of Medicine 2004 117 12 912 918 15629729 source
Not checked in the free run.
- cites [10] Khaw KT Wareham N Bingham S Welch A Luben R Day N Combined impact of health behaviours and mortality in men and women: the EPIC-Norfolk prospective population study PLoS Medicine 2008 5 1 p. e12 18184033 PMC2174962 source
Not checked in the free run.
- cites [11] Sui X LaMonte MJ Laditka JN Cardiorespiratory fitness and adiposity as mortality predictors in older adults Journal of the American Medical Association 2007 298 21 2507 2516 18056904 PMC2692959 source
Not checked in the free run.
May combine two claims.
PremisecitationRegular physical activity offers protection against, and may be useful as a treatment for, a wide variety of chronic diseases associated with low-grade inflammation.
“Regular physical activity offers protection against, and may be useful as a treatment for a wide variety of, chronic diseases associated with low-grade inflammation [12].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [12] Pedersen BK Saltin B Evidence for prescribing exercise as therapy in chronic disease Scandinavian Journal of Medicine & Science in Sports 2006 16 supplement 1 3 63 16451303 source
Not checked in the free run.
May combine two claims.
InterpretationreasoningSkeletal muscle, by contraction, stimulates production and release of myokines, which may influence metabolism and modify cytokine production in tissue and organs.
“The discovery of contracting muscle as a cytokine-producing organ opens a new paradigm; skeletal muscle is an endocrine organ that, by contraction, stimulates the production and release of myokines, which may influence metabolism and modify cytokine production in tissue and organs.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationType 2 diabetes, obesity, and cardiovascular disease are related to a state of low-grade systemic inflammation.
“Type 2 diabetes, obesity, and cardiovascular disease are related to a state of low-grade systemic inflammation [7, 27–29].”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [7] Dandona P Aljada A Bandyopadhyay A Inflammation: the link between insulin resistance, obesity and diabetes Trends in Immunology 2004 25 1 4 7 14698276 source
Not checked in the free run.
- cites [27] Gleeson M Immune function in sport and exercise Journal of Applied Physiology 2007 103 2 693 699 17303714 source
Not checked in the free run.
- cites [28] Pedersen BK Fischer CP Physiological roles of muscle-derived interleukin-6 in response to exercise Current Opinion in Clinical Nutrition and Metabolic Care 2007 10 3 265 271 17414493 source
Not checked in the free run.
- cites [29] Alexandraki K Piperi C Kalofoutis C Singh J Alaveras A Kalofoutis A Inflammatory process in type 2 diabetes: the role of cytokines Annals of the New York Academy of Sciences 2006 1084 89 117 17151295 source
Not checked in the free run.
May combine two claims.
PremisecitationTNF-α infusion increases whole-body lipolysis by 40% with a concomitant increase in FFA clearance, but with no changes in skeletal muscle FFA uptake, release, or oxidation.
“Moreover, it was recently demonstrated that TNF-alpha infusion increases whole-body lipolysis by 40% with a concomitant increase in FFA clearance, but with no changes in skeletal muscle FFA uptake, release, or oxidation [45].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [45] Plomgaard P Fischer CP Ibfelt T Pedersen BK van Hall G Tumor necrosis factor-α modulates human in vivo lipolysis The Journal of Clinical Endocrinology & Metabolism 2008 93 2 543 549 18029463 source
Not checked in the free run.
May combine two claims.
PremisecitationIL-6 enhances lipolysis as well as fat oxidation.
“A number of studies indicate that IL-6 enhances lipolysis, as well as fat oxidation [50, 58].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [50] Petersen EW Carey AL Sacchetti M Acute IL-6 treatment increases fatty acid turnover in elderly humans in vivo and in tissue culture in vitro American Journal of Physiology 2005 288 1 E155 E162 15383370 source
Not checked in the free run.
- cites [58] van Hall G Steensberg A Sacchetti M Interleukin-6 stimulates lipolysis and fat oxidation in humans The Journal of Clinical Endocrinology & Metabolism 2003 88 7 3005 3010 12843134 source
Not checked in the free run.
May combine two claims.
InterpretationreasoningThe IL-6 dose applied in studies showing insulin resistance was supraphysiological and is therefore probably not relevant to human physiology.
“However, the IL-6 dose applied in the latter studies was supraphysiological, and is therefore probably not relevant to human physiology.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationElevated TNF-α is not secondary to the pathological conditions associated with insulin resistance, but plays a direct pathogenic role in glucose metabolism.
“Thus, a number of studies indicate that elevated TNF-α is not secondary to the pathological conditions associated with insulin resistance, but that TNF-α plays a direct pathogenic role in glucose metabolism [29, 40].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [29] Alexandraki K Piperi C Kalofoutis C Singh J Alaveras A Kalofoutis A Inflammatory process in type 2 diabetes: the role of cytokines Annals of the New York Academy of Sciences 2006 1084 89 117 17151295 source
Not checked in the free run.
- cites [40] Plomgaard P Nielsen AR Fischer CP Associations between insulin resistance and TNF-α in plasma, skeletal muscle and adipose tissue in humans with and without type 2 diabetes Diabetologia 2007 50 12 2562 2571 17928988 source
Not checked in the free run.
May combine two claims.
PremisecitationIn vitro studies demonstrate that IL-6 can induce insulin resistance in isolated 3T3-L1 adipocytes and in mice.
“In vitro studies demonstrate that IL-6 can induce insulin resistance in isolated 3T3-L1 adipocytes [51, 52] and in mice [53].”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [51] Rotter V Nagaev I Smith U Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-α, overexpressed in human fat cells from insulin-resistant subjects Journal of Biological Chemistry 2003 278 46 45777 45784 12952969 source
Not checked in the free run.
- cites [52] Fasshauer M Klein J Lossner U Paschke R Interleukin (IL)-6 mRNA expression is stimulated by insulin, isoproterenol, tumour necrosis factor alpha, growth hormone, and IL-6 in 3T3-L1 adipocytes Hormone and Metabolic Research 2003 35 3 147 152 12734774 source
Not checked in the free run.
- cites [53] Kim H-J Higashimori T Park S-Y Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo Diabetes 2004 53 4 1060 1067 15047622 source
Not checked in the free run.
May combine two claims.
PremisecitationWhen diabetes patients were given an rhIL-6 infusion, plasma insulin decreased to levels comparable with age and BMI-matched healthy controls, indicating that IL-6 enhanced insulin sensitivity.
“When diabetes patients were given an rhIL-6 infusion, plasma concentrations of insulin decreased to levels comparable with that in age and BMI (body mass index)-matched healthy controls, indicating that the IL-6 enhanced insulin sensitivity [50].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [50] Petersen EW Carey AL Sacchetti M Acute IL-6 treatment increases fatty acid turnover in elderly humans in vivo and in tissue culture in vitro American Journal of Physiology 2005 288 1 E155 E162 15383370 source
Not checked in the free run.
May combine two claims.
PremisecitationIL-6 deficient mice develop mature-onset obesity and insulin resistance.
“Consistent with this idea, Wallenius et al. 2002 demonstrated that IL-6 deficient mice developed mature-onset obesity and insulin resistance.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Wallenius et al. 2002
Not checked in the free run.
May combine two claims.
PremisereasoningExercise provokes an increase primarily in IL-6, followed by an increase in IL-1ra and IL-10.
“Taken together, exercise provokes an increase primarily in IL-6, followed by an increase in IL-1ra and IL-10.”
Quote in the paperSubstantial claimMay combine two claims.
Premisenone givenIL-6 alone markedly increases both lipolysis and fat oxidation in cell culture experiments.
“cell culture experiments demonstrating that IL-6 alone markedly increases both lipolysis and fat oxidation”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationLevels of TNF-α are markedly elevated in anti-IL-6-treated mice and in IL-6-deficient knockout mice, indicating that circulating IL-6 is involved in the regulation of TNF-α levels.
“and levels of TNF-α are markedly elevated in anti-IL-6-treated mice and in IL-6-deficient knockout mice [67, 68], indicating that circulating IL-6 is involved in the regulation of TNF-α levels.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [67] Matthys P Mitera T Heremans H Van Damme J Billiau A Anti-gamma interferon and anti-interleukin-6 antibodies affect staphylococcal enterotoxin B-induced weight loss, hypoglycemia, and cytokine release in D-galactosamine-sensitized and unsensitized mice Infection and Immunity 1995 63 4 1158 1164 7890366 PMC173128 source
Not checked in the free run.
- cites [68] Mizuhara H O'Neill E Seki N T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6 Journal of Experimental Medicine 1994 179 5 1529 1537 8163936 PMC2191474 source
Not checked in the free run.
May combine two claims.
Premisenone givenIL-6 is typically the first cytokine present in the circulation during exercise, its appearance is by far the most marked, and it precedes the appearance of other cytokines.
“Typically, IL-6 is the first cytokine present in the circulation during exercise, and the appearance of IL-6 in the circulation is by far the most marked and its appearance precedes that of the other cytokines.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationIL-6 and IL-6-regulated acute phase proteins are anti-inflammatory and immunosuppressive, and may negatively regulate the acute-phase response.
“Interleukin-6 is most often classified as a proinflammatory cytokine, although data also suggest that IL-6 and IL-6-regulated acute phase proteins are anti-inflammatory and immunosuppressive, and may negatively regulate the acute-phase response [20].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [20] Pedersen BK The anti-inflammatory effect of exercise: its role in diabetes and cardiovascular disease control Essays in Biochemistry 2006 42 105 117 17144883 source
Not checked in the free run.
May combine two claims.
PremisecitationCirculating IL-6 increases in an exponential fashion up to 100 fold in response to exercise and declines in the postexercise period.
“The level of circulating IL-6 increases in an exponential fashion (up to 100 fold) in response to exercise, and declines in the postexercise period [60–62].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [60] Febbraio MA Pedersen BK Muscle-derived interleukin-6: mechanisms for activation and possible biological roles The FASEB Journal 2002 16 11 1335 1347 12205025 source
Not checked in the free run.
- cites [61] Pedersen BK Hoffman-Goetz L Exercise and the immune system: regulation, integration, and adaptation Physiological Reviews 2000 80 3 1055 1081 10893431 source
Not checked in the free run.
- cites [62] Pedersen BK Steensberg A Schjerling P Exercise and interleukin-6 Current Opinion in Hematology 2001 8 3 137 141 11303145 source
Not checked in the free run.
May combine two claims.
PremisecitationBoth TNF-α and IL-6 induce lipolysis, but only IL-6 appears to induce fat oxidation.
“Of note, whereas it is known that both TNF-α and IL-6 induce lipolysis [40, 49], only IL-6 appears to induce fat oxidation [19, 59].”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [40] Plomgaard P Nielsen AR Fischer CP Associations between insulin resistance and TNF-α in plasma, skeletal muscle and adipose tissue in humans with and without type 2 diabetes Diabetologia 2007 50 12 2562 2571 17928988 source
Not checked in the free run.
- cites [49] Lyngsø D Simonsen L Bülow J Interleukin-6 production in human subcutaneous abdominal adipose tissue: the effect of exercise The Journal of Physiology 2002 543 1 373 378 12181307 PMC2290472 source
Not checked in the free run.
- cites [19] Febbraio MA Pedersen BK Contraction-induced myokine production and release: is skeletal muscle an endocrine organ? Exercise and Sport Sciences Reviews 2005 33 3 114 119 16006818 source
Not checked in the free run.
- cites [59] Bruce CR Dyck DJ Cytokine regulation of skeletal muscle fatty acid metabolism: effect of interleukin-6 and tumor necrosis factor-α American Journal of Physiology 2004 287 4 E616 E621 15149950 source
Not checked in the free run.
May combine two claims.
PremisecitationIL-6 protein is expressed in contracting muscle fibres and IL-6 is released from skeletal muscle during exercise.
“In addition, it has been demonstrated that the IL-6 protein is expressed in contracting muscle fibres and that IL-6 is released from skeletal muscle during exercise [28].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [28] Pedersen BK Fischer CP Physiological roles of muscle-derived interleukin-6 in response to exercise Current Opinion in Clinical Nutrition and Metabolic Care 2007 10 3 265 271 17414493 source
Not checked in the free run.
May combine two claims.
PremisecitationLongitudinal studies show that regular training induces a reduction in CRP level, suggesting that physical activity as such may suppress systemic low-grade inflammation.
“Moreover, the finding in longitudinal studies that regular training induces a reduction in CRP level suggests that the physical activity as such may suppress systemic low-grade inflammation [74, 75, 79, 80].”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [74] Fallon KE Fallon SK Boston T The acute phase response and exercise: court and field sports British Journal of Sports Medicine 2001 35 3 170 173 11375875 PMC1724337 source
Not checked in the free run.
- cites [75] Mattusch F Dufaux B Heine O Mertens I Rost R Reduction of the plasma concentration of C-reactive protein following nine months of endurance training International Journal of Sports Medicine 2000 21 1 21 24 10683094 source
Not checked in the free run.
- cites [79] Stewart LK Flynn MG Campbell WW The influence of exercise training on inflammatory cytokines and C-reactive protein Medicine & Science in Sports & Exercise 2007 39 10 1714 1719 17909397 source
Not checked in the free run.
- cites [80] Goldhammer E Tanchilevitch A Maor I Beniamini Y Rosenschein U Sagiv M Exercise training modulates cytokines activity in coronary heart disease patients International Journal of Cardiology 2005 100 1 93 99 15820291 source
Not checked in the free run.
May combine two claims.
Interpretationnone givenMuscle contraction-induced factors, so-called myokines, may be involved in mediating the health beneficial effects of exercise and play important roles in protection against chronic noncommunicable diseases.
“Muscle contraction-induced factors, so-called myokines, may be involved in mediating the health beneficial effects of exercise and play important roles in the protection against CNCDs, which include cardiovascular conditions, some cancers, and type 2 diabetes.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationcitationThe effect of exercise on the endotoxin-induced TNF-α response could be mimicked by infusion of IL-6, suggesting that IL-6 may be involved in mediating the anti-inflammatory effects of exercise.
“Moreover, the effect of exercise could be mimicked by infusion of IL-6, suggesting that IL-6 may be involved in mediating the anti-inflammatory effects of exercise [69].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [69] Starkie R Ostrowski SR Jauffred S Febbraio M Pedersen BK Exercise and IL-6 infusion inhibit endotoxin-induced TNF-α production in humans The FASEB Journal 2003 17 8 884 886 12626436 source
Not checked in the free run.
The authors state this as an assumption.
The origin of TNF in chronic low-grade systemic inflammation is mainly adipose tissue.
“In the latter case, the stimuli for the cytokine production are not known, but it is assumed that the origin of TNF in chronic low-grade systemic inflammation is mainly the adipose tissue [23–26].”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Improvements from altering health behaviors appear to stem from endocrinological changes that occur with overfatness and following exposure to exercise.
“Where these improvements appear to stem from a number of endocrinological changes that occur with both expression of overfatness and following exposure to exercise that ultimately alters the health status for the individual who is overfat [18,19,26,28,30,32-34].”
Altering any health behaviors leads to a reduction in the risk factors for preventable non-communicable diseases.
“Even if it is well understood that altering any health behaviors leads to a reduction in the risk factors for preventable non-communicable diseases [18,20,26-33].”
Changes in humoral factors are necessary for improvement in health status.
“The changes elicited in humoral factors (e.g., hormone/cytokines, blood lipids and biomarkers of inflammation) are necessary for improvement in health status that many have previously discussed in a number of reviews on this topic [18-21,26,31,32,34,42].”
High circulating insulin is a key indicator for metabolic health issues in overfat adults.
“one of the key indicators for metabolic health issues for adults that are overfat is high levels of circulating insulin”
Any treatment produces effective change toward normal healthy range, leading to reduced CVD risk and improved health.
“any treatment is able to produce an effective change that leads toward a normal “healthy” range, thus leading to a reduced risk for development of cardiovascular disease and improvements in work capacity and overall health”
Cites
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199 · see citing works
Inflammation in atherosclerosis
Libby, P. (2002) · Nature · doi:10.1038/nature01323 · Cited by 8,315 · see citing works
Inflammation in Atherosclerosis
Libby, P. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.179705 · Cited by 3,748 · see citing works
Ridker, P. M., Rifai, N., Rose, L., Buring, J. E., & Cook, N. R. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021993 · Cited by 3,604 · see citing works
The anti-inflammatory effect of exercise
Petersen, A. M. W., & Pedersen, B. K. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00164.2004 · Cited by 3,100 · cited 4× · see citing works
“In particular, the long-term effect of exercise may to some extent be ascribed to the anti-inflammatory response elicited by an acute bout of exercise, which is partly mediated by muscle-derived IL-6 [8, 20, 81].”
BackgroundInfluentialSelf-citationGlobal Burden of Disease and Risk Factors
López, A. D., Mathers, C. D., Ezzati, M., Jamison, D. T. T., & Murray, C. J. L. (2006) · World Bank, Washington, DC eBooks · doi:10.1596/978-0-8213-6262-4 · Cited by 2,693 · see citing works
Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630 · see citing works
Inflammation: the link between insulin resistance, obesity and diabetes
Dandona, P. (2004) · Trends in Immunology · doi:10.1016/j.it.2003.10.013 · Cited by 2,170 · see citing works
Exercise and the immune system: regulation, integration, and adaptation
Pedersen, B. K., & Hoffman-Goetz, L. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.3.1055 · Cited by 1,710 · see citing works
Self-citationPreventing chronic diseases: a vital investment
Vita-Finzi, L., & Who, G. E. (2005) · Cited by 1,686 · see citing works
Evidence for prescribing exercise as therapy in chronic disease
Pedersen, B. K., & Saltin, B. (2006) · Scandinavian Journal of Medicine & Science in Sports · doi:10.1111/j.1600-0838.2006.00520.x · Cited by 1,384 · see citing works
Self-citationInterleukin-6-deficient mice develop mature-onset obesity
Wallenius, V., Wallenius, K., Ahrén, B., Rudling, M., Carlsten, H., Dickson, S. L., Ohlsson, C., & Jansson, J.-O. (2002) · Nature Medicine · doi:10.1038/nm0102-75 · Cited by 1,213 · see citing works
Steensberg, A., van Hall, G., Osada, T., Sacchetti, M., Saltin, B., & Pedersen, B. K. (2000) · The Journal of Physiology · doi:10.1111/j.1469-7793.2000.00237.x · Cited by 1,095 · see citing works
Self-citationRotter, V., Nagaev, I., & Smith, U. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301977200 · Cited by 1,062 · see citing works
Immune function in sport and exercise
Gleeson, M. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00008.2007 · Cited by 1,016 · see citing works
Pro‐ and anti‐inflammatory cytokine balance in strenuous exercise in humans
Ostrowski, K., Rohde, T., Asp, S., Schjerling, P., & Pedersen, B. K. (1999) · The Journal of Physiology · doi:10.1111/j.1469-7793.1999.287ad.x · Cited by 1,014 · see citing works
Self-citationSchindler, R., Mancilla, J., Endres, S., Ghorbani, R., Clark, S., & Dinarello, C. (1990) · Blood · doi:10.1182/blood.v75.1.40.40 · Cited by 1,012 · see citing works
Pro-inflammatory cytokines and adipose tissue
Coppack, S. W. (2001) · Proceedings of The Nutrition Society · doi:10.1079/pns2001110 · Cited by 1,008 · see citing works
Inflammation in Atherosclerosis: From Vascular Biology to Biomarker Discovery and Risk Prediction
Packard, R. R. S., & Libby, P. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.097360 · Cited by 925 · see citing works
Inflammatory Markers and Physical Performance in Older Persons: The InCHIANTI Study
Cesari, M., Penninx, B. W. J. H., Pahor, M., Lauretani, F., Corsi, A. M., Williams, G. R., Guralnik, J. M., & Ferrucci, L. (2004) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/59.3.m242 · Cited by 901 · see citing works
Carey, A. L., Steinberg, G. R., Macaulay, S. L., Thomas, W. G., Holmes, A. G., Ramm, G., Prelovsek, O., Hohnen-Behrens, C., Watt, M. J., James, D. E., et al. (2006) · Diabetes · doi:10.2337/db05-1404 · Cited by 898 · see citing works
Self-citationMuscle‐derived interleukin‐6: mechanisms for activation and possible biological roles
FEBBRAIO, M. A., & PEDERSEN, B. K. (2002) · The FASEB Journal · doi:10.1096/fj.01-0876rev · Cited by 875 · see citing works
Self-citationKhaw, K.-T., Wareham, N., Bingham, S., Welch, A., Luben, R., & Day, N. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050012 · Cited by 840 · see citing works
Exercise and IL‐6 infusion inhibit endotoxin‐induced TNF‐α production in humans
Starkie, R., Ostrowski, S. R., Jauffred, S., Febbraio, M., & Pedersen, B. K. (2003) · The FASEB Journal · doi:10.1096/fj.02-0670fje · Cited by 790 · see citing works
Self-citationInterleukin-6 stimulates lipolysis and fat oxidation in humans
van Hall, G., Steensberg, A., Sacchetti, M., Fischer, C., Keller, C., Schjerling, P., Hiscock, N., Møller, K., Saltin, B., Febbraio, M. A., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021687 · Cited by 767 · see citing works
Self-citationGrand challenges in chronic non-communicable diseases
Daar, A. S., Singer, P. A., Leah Persad, D., Pramming, S. K., Matthews, D. R., Beaglehole, R., Bernstein, A., Borysiewicz, L. K., Colagiuri, S., Ganguly, N., et al. (2007) · Nature · doi:10.1038/450494a · Cited by 701 · see citing works
Cardiorespiratory Fitness and Adiposity as Mortality Predictors in Older Adults
Sui, X., LaMonte, M. J., Laditka, J. N., Hardin, J. W., Chase, N., Hooker, S. P., & Blair, S. N. (2007) · JAMA · doi:10.1001/jama.298.21.2507 · Cited by 640 · see citing works
Plomgaard, P., Bouzakri, K., Krogh-Madsen, R., Mittendorfer, B., Zierath, J. R., & Pedersen, B. K. (2005) · Diabetes · doi:10.2337/diabetes.54.10.2939 · Cited by 627 · see citing works
Self-citationBastard, J., Maachi, M., Nhieu, J. T. V., Jardel, C., Bruckert, É., Grimaldi, A., Robert, J., Capeau, J., & Hainque, B. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.5.8450 · Cited by 625 · see citing works
Association between Physical Activity and Markers of Inflammation in a Healthy Elderly Population
Geffken, D. F., Cushman, M., Burke, G. L., Polak, J. F., Sakkinen, P. A., & Tracy, R. P. (2001) · American Journal of Epidemiology · doi:10.1093/aje/153.3.242 · Cited by 599 · see citing works
Searching for the exercise factor: is IL-6 a candidate?
Pedersen (2003) · Journal of Muscle Research and Cell Motility · doi:10.1023/a:1026070911202 · Cited by 564 · see citing works
Zeyda, M., Farmer, D., Todoric, J., Aszmann, O. C., Speiser, M., Györi, G., Zlabinger, G. J., & Stulnig, T. M. (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803632 · Cited by 553 · see citing works
Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-α
Ruan, H., & Lodish, H. F. (2003) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(03)00052-2 · Cited by 541 · see citing works
Differential Effects of Interleukin-6 and -10 on Skeletal Muscle and Liver Insulin Action In Vivo
Kim, H.-J., Higashimori, T., Park, S.-Y., Choi, H., Dong, J., Kim, Y.-J., Noh, H.-L., Cho, Y.-R., Cline, G., Kim, Y.-B., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.4.1060 · Cited by 534 · see citing works
Fitness versus physical activity patterns in predicting mortality in men
Myers, J., Kaykha, A., George, S., Abella, J., Zaheer, N., Lear, S., Yamazaki, T., & Froelicher, V. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.06.047 · Cited by 521 · see citing works
Mizuhara, H., O'Neill, E., Seki, N., Ogawa, T., Kusunoki, C., Otsuka, K., Satoh, S., Niwa, M., Senoh, H., & Fujiwara, H. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.5.1529 · Cited by 517 · see citing works
The effect of including C-reactive protein in cardiovascular risk prediction models for women
Cook, N. R., Buring, J. E., & Ridker, P. M. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-1-200607040-00128 · Cited by 504 · see citing works
Physical activity and cancer risk: dose-response and cancer, all sites and site-specific
Thune, I., & Furberg, A. (2001) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-200106001-00025 · Cited by 466 · see citing works
Systemic Inflammation, Adipose Tissue Tumor Necrosis Factor, and Leptin Expression
Bulló, M., García‐Lorda, P., Megías-Rangil, I., & Salas‐Salvadó, J. (2003) · Obesity Research · doi:10.1038/oby.2003.74 · Cited by 449 · see citing works
Physical activity and modulation of systemic low-level inflammation
Bruunsgaard, H. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0505247 · Cited by 429 · see citing works
Contraction-Induced Myokine Production and Release: Is Skeletal Muscle an Endocrine Organ?
Febbraio, M. A., & Pedersen, B. K. (2005) · Exercise and Sport Sciences Reviews · doi:10.1097/00003677-200507000-00003 · Cited by 402 · see citing works
Self-citationMattusch, Dufaux, Heine, Mertens, & Rost (2000) · International Journal of Sports Medicine · doi:10.1055/s-2000-8852 · Cited by 389 · see citing works
The evolving role of inflammation in obesity and the metabolic syndrome
Lee, Y.-H., & Pratley, R. E. (2005) · Current Diabetes Reports · doi:10.1007/s11892-005-0071-7 · Cited by 369 · see citing works
Exercise training modulates cytokines activity in coronary heart disease patients
Goldhammer, E., Tanchilevitch, A., Maor, I., Beniamini, Y., Rosenschein, U., & Sagiv, M. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2004.08.073 · Cited by 363 · see citing works
The role of IL-6 in mediating the anti-inflammatory effects of exercise.
Petersen, A. M. W., & Pedersen, B. K. (2006) · PubMed · Cited by 354 · see citing works
Self-citationM-CSF, TNFα and RANK ligand promote osteoclast survival by signaling through mTOR/S6 kinase
Glantschnig, H., Fisher, J. E., Wesolowski, G., Rodan, G. A., & Reszka, A. A. (2003) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401285 · Cited by 350 · see citing works
The anti-inflammatory effect of exercise: its role in diabetes and cardiovascular disease control
Pedersen, B. K. (2006) · Essays in Biochemistry · doi:10.1042/bse0420105 · Cited by 349 · see citing works
Self-citationPhysical activity and diabetes prevention
LaMonte, M. J., Blair, S. N., & Church, T. S. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00193.2005 · Cited by 340 · see citing works
Petersen, E. W., Carey, A. L., Sacchetti, M., Steinberg, G. R., Macaulay, S. L., Febbraio, M. A., & Pedersen, B. K. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00257.2004 · Cited by 311 · see citing works
Self-citationInflammatory Process in Type 2 Diabetes: The Role of Cytokines
ALEXANDRAKI, K., PIPERI, C., KALOFOUTIS, C., SINGH, J., ALAVERAS, A., & KALOFOUTIS, A. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1372.039 · Cited by 309 · see citing works
Predicting death from tumour necrosis factor-alpha and interleukin-6 in 80-year-old people
BRUUNSGAARD, H., LADELUND, S., PEDERSEN, A. N., SCHROLL, M., JØRGENSEN, T., & PEDERSEN, B. K. (2003) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.2003.02137.x · Cited by 300 · see citing works
Self-citationThe Influence of Exercise Training on Inflammatory Cytokines and C-Reactive Protein
STEWART, L. K., FLYNN, M. G., CAMPBELL, W. W., CRAIG, B. A., ROBINSON, J. P., TIMMERMAN, K. L., MCFARLIN, B. K., COEN, P. M., & TALBERT, E. (2007) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e31811ece1c · Cited by 283 · see citing works
Signaling Specificity of Interleukin-6 Action on Glucose and Lipid Metabolism in Skeletal Muscle
Al-Khalili, L., Bouzakri, K., Glund, S., Lönnqvist, F., Koistinen, H. A., & Krook, A. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0490 · Cited by 250 · see citing works
Fischer, C. P., Berntsen, A., Perstrup, L. B., Eskildsen, P., & Pedersen, B. K. (2007) · Scandinavian Journal of Medicine & Science in Sports · doi:10.1111/j.1600-0838.2006.00602.x · Cited by 230 · see citing works
Self-citationPhysiological roles of muscle-derived interleukin-6 in response to exercise
Pedersen, B. K., & Fischer, C. P. (2007) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e3280ebb5b3 · Cited by 227 · see citing works
Self-citationPedersen, B. K., Steensberg, A., & Schjerling, P. (2001) · Current Opinion in Hematology · doi:10.1097/00062752-200105000-00002 · Cited by 223 · see citing works
Self-citationInterleukin-6 Directly Increases Glucose Metabolism in Resting Human Skeletal Muscle
Glund, S., Deshmukh, A., Long, Y. C., Moller, T., Koistinen, H. A., Caidahl, K., Zierath, J. R., & Krook, A. (2007) · Diabetes · doi:10.2337/db06-1733 · Cited by 219 · see citing works
Influence of Metabolic Syndrome on Biomarkers of Oxidative Stress and Inflammation in Obese Adults
Guilder, G. P. V., Hoetzer, G. L., Greiner, J. J., Stauffer, B. L., & DeSouza, C. A. (2006) · Obesity · doi:10.1038/oby.2006.248 · Cited by 211 · see citing works
Tisi, P. V., Hulse, M., Chulakadabba, A., Gosling, P., & Shearman, C. P. (1997) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/s1078-5884(97)80283-3 · Cited by 199 · see citing works
IL-6 signalling in exercise and disease
Pedersen, B. K. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351295 · Cited by 187 · see citing works
Self-citationInfluence of TNF-α and IL-6 infusions on insulin sensitivity and expression of IL-18 in humans
Krogh‐Madsen, R., Plomgaard, P., Møller, K., Mittendorfer, B., & Pedersen, B. K. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00471.2005 · Cited by 181 · see citing works
Self-citationBruce, C. R., & Dyck, D. J. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00150.2004 · Cited by 178 · see citing works
Interleukin-6 does/does not have a beneficial role in insulin sensitivity and glucose homeostasis
Pedersen, B. K., & Febbraio, M. A. (2006) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01208.2006 · Cited by 177 · see citing works
Self-citationCarey, A. L., Bruce, C. R., Sacchetti, M., Anderson, M. J., Olsen, D. B., Saltin, B., Hawley, J. A., & Febbraio, M. A. (2004) · Diabetologia · doi:10.1007/s00125-004-1403-x · Cited by 170 · see citing works
Interleukin‐6 production in human subcutaneous abdominal adipose tissue: the effect of exercise
Lyngsø, D., Simonsen, L., & Bülow, J. (2002) · The Journal of Physiology · doi:10.1113/jphysiol.2002.019380 · Cited by 155 · see citing works
Plomgaard, P., Nielsen, A. R., Fischer, C. P., Mortensen, O. H., Broholm, C., Penkowa, M., Krogh-Madsen, R., Erikstrup, C., Lindegaard, B., Petersen, A. M. W., et al. (2007) · Diabetologia · doi:10.1007/s00125-007-0834-6 · Cited by 152 · see citing works
Self-citationSteensberg, A., Fischer, C. P., Sacchetti, M., Keller, C., Osada, T., Schjerling, P., van Hall, G., Febbraio, M. A., & Pedersen, B. K. (2003) · The Journal of Physiology · doi:10.1111/j.1469-7793.2003.00631.x · Cited by 152 · see citing works
Self-citationSteensberg, A., Fischer, C. P., Sacchetti, M., Keller, C., Osada, T., Schjerling, P., van Hall, G., Febbraio, M. A., & Pedersen, B. K. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2002.032938 · Cited by 152 · see citing works
Fasshauer, M., Klein, J., Lossner, U., & Paschke, R. (2003) · Hormone and Metabolic Research · doi:10.1055/s-2003-39075 · Cited by 151 · see citing works
Physical activity, physical fitness and longevity
Lee, I. M., Paffenbarger, R. S., & Hennekens, C. H. (1997) · Aging Clinical and Experimental Research · doi:10.1007/bf03340123 · Cited by 146 · see citing works
Is the anti-inflammatory effect of regular exercise responsible for reduced cardiovascular disease?
Wilund, K. R. (2007) · Clinical Science · doi:10.1042/cs20060368 · Cited by 138 · see citing works
Matthys, P., Mitera, T., Heremans, H., Van Damme, J., & Billiau, A. (1995) · Infection and Immunity · doi:10.1128/iai.63.4.1158-1164.1995 · Cited by 134 · see citing works
Gil, Á., Aguilera, C. M., Gil‐Campos, M., & Cañete, R. (2007) · British Journal Of Nutrition · doi:10.1017/s0007114507838050 · Cited by 127 · see citing works
The acute phase response and exercise: court and field sports
Fallon, K. E., Fallon, S. K., & Boston, T. (2001) · British Journal of Sports Medicine · doi:10.1136/bjsm.35.3.170 · Cited by 122 · see citing works
Rydén, M., & Arner, P. (2007) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2007.01854.x · Cited by 118 · see citing works
Interleukin-6 serum levels and genotypes influence the risk for myocardial infarction
Bennet, A. (2003) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2003.08.029 · Cited by 113 · see citing works
Tumor Necrosis Factor-α Modulates Human<i>in Vivo</i>Lipolysis
Plomgaard, P., Fischer, C. P., Ibfelt, T., Pedersen, B. K., & van Hall, G. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1761 · Cited by 97 · see citing works
Self-citationLow-grade systemic inflammation in overweight children: impact of physical fitness
Halle, M., Korsten-Reck, U., Wolfarth, B., & Berg, A. (2026) · PubMed · doi:10.22029/eir.2004.1606 · Cited by 88 · see citing works
Public Policy & the Challenge of Chronic Noncommunicable Diseases
Adeyi, O., Smith, O., & Robles, S. C. (2007) · World Bank, Washington, DC eBooks · doi:10.1596/978-0-8213-7044-5 · Cited by 87 · see citing works
The Acute Stress-Induced Immunoenhancement Hypothesis
Edwards, K. M., Burns, V. E., Carroll, D., Drayson, M. T., & Ring, C. (2007) · Exercise and Sport Sciences Reviews · doi:10.1097/jes.0b013e3180a031bd · Cited by 72 · see citing works
Plasma Cytokines, Metabolic Syndrome, and Atherosclerosis in Humans
Reilly, M. P., Rohatgi, A., McMahon, K., Wolfe, M. L., Pinto, S. C., Rhodes, T., Girman, C., & Rader, D. J. (2007) · Journal of Investigative Medicine · doi:10.2310/6650.2007.06013 · Cited by 42 · see citing works
DIMINISHED ERK 1/2 AND p38 MAPK PHOSPHORYLATION IN SKELETAL MUSCLE DURING SEPSIS
Vary, T. C., Deiter, G. M., & Lang, C. H. (2004) · Shock · doi:10.1097/01.shk.0000144131.13900.ff · Cited by 24 · see citing works
Pedersen, B. K. (2007) · American Journal of Lifestyle Medicine · doi:10.1177/1559827607301410 · Cited by 14 · see citing works
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- 10.1038/450494a · DOI · Paper page
Cited by
Sorted by citations
Gleeson, M., Bishop, N. C., Stensel, D. J., Lindley, M. R., Mastana, S. S., & Nimmo, M. A. (2011) · Nature Reviews Immunology · doi:10.1038/nri3041 · Cited by 2,470 · see citing works
Alternative macrophage activation and metabolism
Odegaard, J. I., & Chawla, A. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130138 · Cited by 640 · see citing works
Bennett, J. M., Reeves, G., Billman, G. E., & Sturmberg, J. P. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00316 · Cited by 531 · see citing works
Pedersen, B. K. (2013) · Comprehensive physiology · doi:10.1002/cphy.c120033 · Cited by 516 · see citing works
Self-citationExercise effects on depression: Possible neural mechanisms
Gujral, S., Aizenstein, H., Reynolds, C. F., Butters, M. A., & Erickson, K. I. (2017) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2017.04.012 · Cited by 334 · see citing works
Exosomes as Mediators of the Systemic Adaptations to Endurance Exercise
Safdar, A., & Tarnopolsky, M. A. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a029827 · Cited by 203 · see citing works
Cellular and molecular mechanisms of immunomodulation in the brain through environmental enrichment
Singhal, G., Jaehne, E. J., Corrigan, F., & Baune, B. T. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00097 · Cited by 186 · see citing works
Clark, J. E. (2015) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/s40200-015-0154-1 · Cited by 158 · see citing works
Joggin’ the Noggin: Towards a Physiological Understanding of Exercise-Induced Cognitive Benefits
Stimpson, N. J., Davison, G., & Javadi, A.-H. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.03.018 · Cited by 134 · see citing works
Ergun, M., Eyigor, S., Karaca, B., Kisim, A., & Uslu, R. (2013) · European Journal of Cancer Care · doi:10.1111/ecc.12068 · Cited by 127 · see citing works
Inflammation and reactivation of latent herpesviruses in older adults
Bennett, J. M., Glaser, R., Malarkey, W. B., Beversdorf, D. Q., Peng, J., & Kiecolt-Glaser, J. K. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.11.007 · Cited by 118 · see citing works
Gamas, L., Matafome, P., & Seiça, R. (2015) · Journal of Diabetes Research · doi:10.1155/2015/359159 · Cited by 114 · see citing works
Rosa Neto, J. C., Lira, F. S., Oyama, L. M., Zanchi, N. E., Yamashita, A. S., Batista, M. L., Oller do Nascimento, C. M., & Seelaender, M. (2009) · European Journal of Applied Physiology · doi:10.1007/s00421-009-1070-1 · Cited by 112 · see citing works
Impact of resistance training on the autophagy-inflammation-apoptosis crosstalk in elderly subjects
Mejías-Peña, Y., Estébanez, B., Rodriguez-Miguelez, P., Fernandez-Gonzalo, R., Almar, M., de Paz, J. A., González-Gallego, J., & Cuevas, M. J. (2017) · Aging · doi:10.18632/aging.101167 · Cited by 102 · see citing works
Ligibel, J. A., Dillon, D., Giobbie-Hurder, A., McTiernan, A., Frank, E., Cornwell, M., Pun, M., Campbell, N., Dowling, R. J. O., Chang, M. C., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-3143 · Cited by 100 · see citing works
Booth, F. W., & Laye, M. J. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2009.179507 · Cited by 99 · see citing works
Myokines, physical activity, insulin resistance and autoimmune diseases
Díaz, B. B., González, D. A., Gannar, F., Pérez, M. C. R., & de León, A. C. (2018) · Immunology Letters · doi:10.1016/j.imlet.2018.09.002 · Cited by 82 · see citing works
Forti, L. N., Njemini, R., Beyer, I., Eelbode, E., Meeusen, R., Mets, T., & Bautmans, I. (2014) · AGE · doi:10.1007/s11357-014-9704-6 · Cited by 67 · see citing works
Re Cecconi, A. D., Forti, M., Chiappa, M., Zhu, Z., Zingman, L. V., Cervo, L., Beltrame, L., Marchini, S., & Piccirillo, R. (2019) · Cancers · doi:10.3390/cancers11101541 · Cited by 66 · see citing works
Therapeutic effects of Qigong in patients with COPD: a randomized controlled trial
Liu, X.-D., Jin, H.-Z., Ng, B. H.-P., Gu, Y.-H., Wu, Y.-C., & Lu, G. (2012) · Hong Kong Journal of Occupational Therapy · doi:10.1016/j.hkjot.2012.06.002 · Cited by 50 · see citing works
Saner, N. J., Bishop, D. J., & Bartlett, J. D. (2018) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2017.01.001 · Cited by 41 · see citing works
Clark, J. E. (2012) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/2251-6581-11-19 · Cited by 19 · see citing works
Zwetsloot, K. A., Nedergaard, A., Gilpin, L. T., Childs, T. E., & Booth, F. W. (2012) · Biogerontology · doi:10.1007/s10522-012-9382-7 · Cited by 11 · see citing works
Alves Guimarães, M. S., Araújo dos Santos, C., da Silva Castro, J., Juvanhol, L. L., Canaan Rezende, F. A., Martinho, K. O., & Ribeiro, A. Q. (2021) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2020.11.004 · Cited by 10 · see citing works
- Authors
- Mathur, N., & Pedersen, B. K.
- Affiliations
- University of Copenhagen (DK)
- Corresponding author
- Pedersen, Bente Klarlund
- Venue
- Mediators of Inflammation
- Publisher
- Wiley
- Published
- 2008-01
- Volume
- 2008
- Issue
- 1
- Pages
- 109502-109502
- ISSN
- 0962-9351 (ISSN-L)
- 1466-1861
- PMC
- PMC2615833
- OpenAlex
- W1987782779
- Semantic Scholar
- bb0e9ef8fc3f1a7a34688b0fd8f07482ebfc580c
- Cited by
- 514
- References
- 83
- Citations by year
- 2026: 19 · 2025: 22 · 2024: 21 · 2023: 20 · 2022: 36 · 2021: 30 · 2020: 41 · 2019: 28 · 2018: 24 · 2017: 35 · 2016: 33 · 2015: 32 · 2014: 33 · 2013: 24 · 2012: 38
- FWCI
- 3.05
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Mediators of Inflammation (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Danmarks Grundforskningsfond (02-512-55, LSHM-CT-2004-005272 EXGENESIS)
- Danish Medical Research Council (02-512-55, LSHM-CT-2004-005272 EXGENESIS)
- European Commission (02-512-55, LSHM-CT-2004-005272 EXGENESIS)
- Københavns Universitet (02-512-55, LSHM-CT-2004-005272 EXGENESIS)
- Topics
- Health Sciences › Medicine › Rehabilitation › Exercise and Physiological Responses
- Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology › Physical Activity and Health
- Keywords
- physical activity, low-grade inflammation, non-communicable diseases, myokines, interleukin-6, anti-inflammatory effects of exercise, insulin resistance, atherosclerosis, type 2 diabetes, cancer
- MeSH terms
- Humans, Inflammation, Exercise, Interleukin-6, Muscle, Skeletal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-10.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-10.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review